CBLL
CeriBell, Inc. · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +30.0% ·
Aktienfluss +8.4% ·
neue Nettopositionen +20.0%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 55 | +3 | 18.41M | $358.31M | +6 | −3 |
| Q1 2026 | 54 | +2 | 17.21M | $315.46M | +5 | −3 |
| Q4 2025 | 52 | +2 | 15.60M | $342.15M | +3 | −1 |
| Q3 2025 | 13 | -1 | 10.65M | $122.41M | — | −1 |
| Q2 2025 | 11 | +3 | 9.35M | $175.16M | +4 | −1 |
| Q1 2025 | 5 | -4 | 940.06K | $18.06M | — | −4 |
| Q4 2024 | 9 | +8 | 1.55M | $40.23M | +8 | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 4.84M | — | $90.63M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.84M | — | $90.63M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.84M | — | $90.63M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 4.84M | — | $90.63M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 4.84M | — | $90.63M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 1.52M | — | $28.46M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 1.52M | — | $28.46M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 1.52M | — | $28.46M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 1.52M | — | $28.46M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 1.52M | — | $28.46M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 1.52M | — | $28.46M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 1.52M | — | $28.46M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passiv) | 1.33M | — | $24.85M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passiv) | 1.33M | — | $24.85M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passiv) | 1.33M | — | $24.85M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passiv) | 1.33M | — | $24.85M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passiv) | 1.33M | — | $24.85M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 470.15K | +24.7% | $8.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passiv) | 447.94K | +55.4% | $8.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passiv) | 447.94K | +55.4% | $8.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passiv) | 384.35K | +76.0% | $7.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Two Sigma Investments ✦ | 164.64K | Neu | $3.08M | 0.0% | New | 1 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 76.17K | Neu | $1.43M | 0.0% | New | 1 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 76.17K | Neu | $1.43M | 0.0% | New | 1 | SEC ↗ |
| 25 | Point72 Asset Management ✦ | 66.43K | Neu | $1.24M | 0.0% | New | 1 | SEC ↗ |
| 26 | Marshall Wace ✦ | 44.14K | +41.4% | $826,798 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 12.47K | Neu | $234,000 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Two Sigma Investments | $3.08M | 0.0% |
| Citadel Advisors | $1.43M | 0.0% |
| Citadel Advisors | $1.43M | 0.0% |
| Point72 Asset Management | $1.24M | 0.0% |
| T. Rowe Price | $234,000 | 0.0% |
Ausgestiegen
| Soros Fund Management | $487,089 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 121 Inhaber, 29.58M Anteile, $536.67M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer · 859 Ant. · $20,573
Officer · 1.52K Ant. · $36,534
Officer, Director · 6.07K Ant. · $145,753
Officer · 1.98K Ant. · $47,536
Officer · 993 Ant. · $23,852
Officer · 1.36K Ant. · $32,691
Officer, Director · 31.41K Ant. · $786,317
Officer · 33.51K Ant. · $838,805
Officer · 990 Ant. · $24,750
Officer, Director · 2.20K Ant. · $54,975
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik